BUY Biocon Ltd — Prakash Gaba
byPrakash GabaHorizon: NA (inferred Intraday)18 Aug 2026, 10:01 am ISTvia CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Biocon shares rise 2% after USFDA approval for Yesintek single-dose prefilled autoinjector
NewsEt-Markets·18 Aug · today
1 advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·18 Aug · today
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Biocon
- BUY — Kunal Bothra22 Oct 2026 · ~2 weeks · target ₹345 · SL hit
- SELL — Rajesh Satpute9 Oct 2026 · ~3 months · target ₹335 · Active
- BUY — Axis Securities19 Sept 2026 · ~3 months · target ₹424 · Active
- BUY — Prakash Gaba17 Sept 2026 · ~2 weeks · target ₹390 · Target hit
- BUY — Vikas Salunkhe, Nirmal Bang Securities27 Aug 2026 · ~2 weeks · target ₹440 · SL hit
More from Prakash Gaba
- SELL Kalyan Jewellers India23 Oct 2026 · ~2 weeks · target ₹510 · Target hit
- BUY Shilpa Medicare23 Oct 2026 · ~2 weeks · target ₹900 · SL hit
- SELL Ather Energy23 Oct 2026 · Same day · target ₹1,380 · Target hit
- BUY UltraTech Cement23 Oct 2026 · Same day · target ₹11,200 · SL hit
- BUY The Indian Hotels Company22 Oct 2026 · Next day · target ₹800 · SL hit

